Genomtec S.A.
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysi… Read more
Genomtec S.A. (GMT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.212x
Based on the latest financial reports, Genomtec S.A. (GMT) has a cash flow conversion efficiency ratio of -0.212x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-2.20 Million) by net assets (zł10.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genomtec S.A. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Genomtec S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genomtec S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genomtec S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Triunfo Participações e Investimentos S.A
SA:TPIS3
|
0.181x |
|
E for L Aim Public Company Limited
BK:EFORL
|
0.037x |
|
Innovative Designs
PINK:IVDN
|
0.044x |
|
TLGUF
PINK:TLGUF
|
0.029x |
|
Lanson BCC SA
PA:ALLAN
|
-0.010x |
|
Asefa Public Company Limited
BK:ASEFA
|
0.121x |
|
Innodep Inc.
KQ:303530
|
-0.187x |
|
Clientron Corp.
TWO:8119
|
-0.034x |
Annual Cash Flow Conversion Efficiency for Genomtec S.A. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Genomtec S.A. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł7.60 Million | zł-6.72 Million | -0.884x | +7.74% |
| 2023-12-31 | zł8.30 Million | zł-7.95 Million | -0.958x | -24.64% |
| 2022-12-31 | zł4.93 Million | zł-3.79 Million | -0.768x | +89.74% |
| 2021-12-31 | zł738.00K | zł-5.53 Million | -7.491x | -2155.20% |
| 2020-12-31 | zł7.57 Million | zł-2.52 Million | -0.332x | +78.32% |
| 2019-12-31 | zł1.11 Million | zł-1.69 Million | -1.532x | -- |